Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications
2011

COX-2 and VEGF-C in Gastric Cancer

Sample size: 56 publication Evidence: moderate

Author Information

Author(s): Gou Hong-Feng, Chen Xin-Chuan, Zhu Jiang, Jiang Ming, Yang Yu, Cao Dan, Hou Mei

Primary Institution: West China Hospital, Sichuan University, PR China

Hypothesis

The study aims to test the expression of COX-2 and VEGF-C in human gastric cancer and analyze their correlation with lymphatic vessel density, clinicopathologic features, and survival prognosis.

Conclusion

COX-2 expression was associated with survival time, but it was not correlated with VEGF-C or lymphatic vessel density.

Supporting Evidence

  • COX-2 expression was found in 69.64% of gastric carcinoma cases.
  • VEGF-C expression was found in 55.36% of gastric carcinoma cases.
  • Peritumoral lymphatic vessel density was significantly higher than in normal and intratumoral tissue.
  • Higher COX-2 expression correlated with poorer survival outcomes.
  • Age, COX-2 expression, and peritumoral lymphatic vessel density were independent prognostic factors.

Takeaway

This study looked at how two proteins, COX-2 and VEGF-C, relate to cancer in the stomach and found that while COX-2 might affect how long patients live, it doesn't seem to help in forming new lymphatic vessels.

Methodology

Immunohistochemistry was used to analyze COX-2, VEGF-C, and lymphatic vessel density in gastric adenocarcinomas.

Limitations

The study's findings may be influenced by the small sample size and retrospective nature.

Participant Demographics

56 patients (35 males and 21 females) with a mean age of 56.2 years.

Statistical Information

P-Value

P = 0.003 for lymph node metastasis correlation; P = 0.05 for invasion depth correlation.

Confidence Interval

95% confidence interval for age: 1.228-6.805; for COX-2: 1.192-8.828; for LVD: 1.778-10.360.

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1756-9966-30-14

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication